Zobrazeno 1 - 10
of 11
pro vyhledávání: '"W H, Dere"'
Publikováno v:
Clinical therapeutics. 14(4)
The use of cefaclor advanced formulation (cefaclor AF) in the treatment of pneumonia caused by susceptible organisms was investigated in a multi-center trial conducted in the United Kingdom and the United States. A total of 266 patients were enrolled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::873783454401e80aa51a1c263a0c4a81
https://pubmed.ncbi.nlm.nih.gov/1525791
https://pubmed.ncbi.nlm.nih.gov/1525791
Publikováno v:
Clinical therapeutics. 14(3)
Cefaclor advanced formulation (cefaclor AF) was compared with cefaclor for the treatment of skin and skin-structure infections in a double-blind study at 28 centers in North America. Of the 563 patients originally randomized, 278 patients received ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e1b25ce9c22a8dca3bff1a893be8edc0
https://pubmed.ncbi.nlm.nih.gov/1638588
https://pubmed.ncbi.nlm.nih.gov/1638588
Publikováno v:
Clinical therapeutics. 14(2)
In this single-blind study, 488 patients with acute bronchitis were randomly assigned to receive 400 mg of loracarbef twice daily or 500/125 mg of amoxicillin/clavulanate three times daily for seven days. Treatment efficacy was evaluated in 98 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa87b315e984c48e11ee31e651b8fa16
https://pubmed.ncbi.nlm.nih.gov/1611641
https://pubmed.ncbi.nlm.nih.gov/1611641
Publikováno v:
Postgraduate medical journal. 68
Two different doses of cefaclor advanced formulation (AF), a new sustained-release formulation of cefaclor, were compared with the regular formulation of cefaclor for efficacy and safety in the treatment of uncomplicated cystitis and asymptomatic bac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::778abe20e746482959cbf26fdc0a7c40
https://pubmed.ncbi.nlm.nih.gov/1287620
https://pubmed.ncbi.nlm.nih.gov/1287620
Publikováno v:
Postgraduate medical journal. 68
The safety of cefaclor advanced formulation (cefaclor AF) was evaluated in 3,272 patients participating in 11 controlled clinical trials in comparison with cefaclor (2,210 patients) for a variety of infectious illnesses. Daily doses of cefaclor AF ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2d1eccb517a655a6d529181b56c17fb9
https://pubmed.ncbi.nlm.nih.gov/1287622
https://pubmed.ncbi.nlm.nih.gov/1287622
Publikováno v:
Clinical therapeutics. 14(1)
In this double-blind study, 319 patients (133 men, 186 women) with acute bronchitis were randomly assigned to receive 200 mg of loracarbef twice daily (n = 160; mean age, 42 years) or 250 mg of cefaclor thrice daily (n = 159; mean age, 43 years) for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7d79b2aa2c7f2381eeb4f05c400e7781
https://pubmed.ncbi.nlm.nih.gov/1576625
https://pubmed.ncbi.nlm.nih.gov/1576625
Publikováno v:
Postgraduate medical journal. 68
Two prospective randomized, double-blind, parallel studies were carried out in Europe to compare cefaclor advanced formulation (cefaclor AF) with cefaclor in the treatment of acute bronchitis caused by susceptible pathogens. A total of 1,321 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::36aca85d0d46aeec9f4845d4b12889d5
https://pubmed.ncbi.nlm.nih.gov/1287614
https://pubmed.ncbi.nlm.nih.gov/1287614
Publikováno v:
Postgraduate medical journal. 68
Two double-blind, double-dummy, randomized multicentre studies compared the safety and efficacy of 10-day regimens of cefaclor advanced formulation (cefaclor AF) (375 mg twice daily) with cefaclor (250 mg three times daily) in the treatment of proven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a21280d977210ce7d81f136a06bf4b8b
https://pubmed.ncbi.nlm.nih.gov/1287618
https://pubmed.ncbi.nlm.nih.gov/1287618
Autor:
W H, Dere, G C, Groggel
Publikováno v:
Geriatrics. 45(7)
Diabetic nephropathy is an important clinical entity in the geriatric population. One half of newly enrolled patients in dialysis programs have non-insulin-dependent diabetes mellitus (NIDDM), and the number of NIDDM patients with chronic renal insuf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aaaebd2e1d1dd45c9b327621e27611a4
https://pubmed.ncbi.nlm.nih.gov/2194907
https://pubmed.ncbi.nlm.nih.gov/2194907
Autor:
C M, Mendel, R F, Klein, D A, Chappell, W H, Dere, B J, Gertz, J H, Karam, T N, Lavin, C, Grunfeld
Publikováno v:
JAMA. 255(5)
We conducted a double-blind, placebo-controlled, crossover study of the effectiveness of amitriptyline and fluphenazine in alleviating the pain of diabetic peripheral neuropathy in six diabetic patients. Pain was evaluated by the patients with a grap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::498b54f7a60586e6a4f34437c1523b11
https://pubmed.ncbi.nlm.nih.gov/3511312
https://pubmed.ncbi.nlm.nih.gov/3511312